Latest news
- Beating Blood Cancers Blog
- Our publications
- Dedicated to beating blood cancers
- Disease newsletter archive
- Lifeblood
- Lifeblood: Issue 1, 2020
- Australia’s Top 100 Blood Cancer Minds are on a mission
- Caring for the Carer
- Davina’s selfless generosity could spark research breakthrough
- Investing in the researchers of tomorrow, today
- Join Team Beat Blood Cancer
- Keep your wheels turning for blood cancer
- Louis’ family thank you for amazing Christmas spirit
- Meet our new chairman, Dr Carrie Hillyard
- Meet Professor Tim Hughes from the Blood Cancer Taskforce
- The one in 110,000: Neda’s story
- WA project a step forward for people with blood cancer
- Lifeblood: Issue 2, 2019
- Subscribe & past issues
- Lifeblood: Issue 1, 2020
- Myeloma News
- Myeloma News: March 2020
- Viruses & blood cancer – what you need to know
- Leukaemia Foundation invests $2.6m+ in innovative myeloma research
- PBAC considers plitidepsin for myeloma
- The tale of ‘the terrible twosome’ #kickingmyelomasbutt
- Caring for the Carer
- Australians are swabbing a cheek to save a life
- What’s CAR T-cell therapy?
- Myeloma News: March 2020
- Willing to help
- Lymphoma News
- Lymphoma News: October 2019
- ‘First of its kind’ blood cancer report proposes new optimal care pathway for people with lymphoma
- ABMDR recruitment campaign – 5,000 new stem cell donors by September 2020
- Bronwyn advocated for when and where she was treated
- Shine a light on blood cancer at Light the Night
- WhiMSICAL study – on the way to 1000 participants and ‘big data’
- Lymphoma News: August 2019
- Lymphoma News: June 2019
- Lymphoma News: October 2019
- MDS News
- MDS News: October 2019
- ‘First of its kind’ blood cancer report includes opportunities for improved treatment for MDS
- ABMDR recruitment campaign – 5,000 new stem cell donors by 2020
- Merrick from Berwick has “reported for duty” since 2012
- Quest to better understand MDS and find out more effective therapies
- Shine a light on blood cancer at Light the Night
- MDS News: September 2019
- MDS News: October 2019
- CLL News
- CLL News: November 2019
- CLL News: September 2019
- Cancer Concierge Pilot: Assessing CLL needs and providing targeted interventions
- Chemo-free drug – Venetoclax – now listed on the PBS for CLL
- Going through treatment has taken the worry out of watch and wait for Patricia
- Information, insights, even exercise covered at the CLL patient forum
- September spotlights blood cancer and our bold new goal
- MPN News
- MPN News: February 2020
- Ken isn’t ruled by his MPN and is optimistic about his future
- New classifications of MPN mean better diagnostics and more definitive prognoses
- ABMDR recruitment campaign – 5,000 new stem cell donors by September 2020
- Caring for the Carer
- Moving towards achieving the vision of Zero Lives Lost to Blood Cancer by 2035
- MPN News: February 2020
- CML News
- Moving towards achieving the vision of Zero Lives Lost to Blood Cancer by 2035
- Q&A: Professor Timothy Hughes – Part 1
- Q&A: Professor Timothy Hughes – Part 2
- Rick’s “very happy” with his decision to change to generic imatinib
- Asciminib – the biggest breakthrough yet in CML treatment
- Caring for the Carer
- A bone marrow transplant saved Judi’s life after a shock diagnosis
- ALL News
- ALL News: March 2020
- Viruses & blood cancer – what you need to know
- Brett’s well and back living in the moment
- Leukaemia Foundation invests $3.9m+ in innovative ALL research
- PBS listing of blinatumomab extended
- Understanding immune system behaviour in blood cancers
- Australians are swabbing a cheek to save a life
- Caring for the Carer
- What’s CAR T-cell therapy?
- ALL News: March 2020
- AML News
- Amyloidosis News
- Living Well News
- Living Well News: Issue 1 / 2019
- Cancer-related fatigue – what it is, how it can affect you and how to manage it
- Cherryl meditates to reduce stress and for her healing
- Cooking for chemo recipes: comfort food for winter
- Talking humanity in healthcare with David Joske
- Tereena goes to her “happy place” when she’s in pain or discomfort
- The mind/body connection in healing
- Living Well News: Issue 2 / 2019
- Living Well News: Issue 1 / 2019
- Subscribe
- Latest news
- Social media
- Media contacts
Blood cancer patient needs could go unmet as incidence rates rise
Monday, 14 January 2019,
The number of Australians living with a blood cancer is expected to rise around 30 per cent over the next decade, according to new Leukaemia Foundation analysis as it launches World’s Greatest Shave this week.
Currently 12,800 Australians are diagnosed with a blood cancer like leukaemia, lymphoma and myeloma every
Therapeutic Goods Administration (TGA) has today approved the use of the first CAR-T therapy in Australia
Therapeutic Goods Administration (TGA) has today approved the use of the first CAR-T therapy in Australia.
A revolutionary cancer therapy that supercharges a patient’s immune cells to hunt and destroy cancer cells has been approved for use in Australia, ushering in a new era in medicine.
The TGA has
Leukaemia Foundation receives HONcode certification
Friday, 07 December 2018
The Leukaemia Foundation has been granted prestigious HONcode certification for its high standard of reliable, ethical and trustworthy health and medical content featured throughout its digital communications platforms.
The HONcode is an international standard for health and medical websites issued by the Health on the Net Foundation,
Researchers at the Peter MacCallum Cancer Centre in Melbourne believe a new combination therapy for mantle cell lymphoma could lead to a cure in almost 100 per cent of cases.
Wednesday, 05 December 2018
A story in the Sydney Morning Herald recently reported Australian researchers were closing in on a cure for the disease which was considered a “death sentence” as little as three years ago.
Peter MacCallum Cancer Centre Professor Sarah-Jane Dawson said dozens of people living with mantle
New PBS listing vital to Australians living with Acute Myeloid Leukaemia
Friday, 30 November 2018
Leukaemia Foundation CEO Mr Bill Petch has today supported the Health Minister Mr Greg Hunt’s Pharmaceuticals Benefits Scheme (PBS) listing announcement of midostaurin (Rydapt®), a targeted therapy that is considered to be an important advancement in the treatment of Acute Myeloid Leukaemia (AML) in 25 years.
Mr
Leukaemia Foundation and HSANZ Jointly Funds Three PhD Investigators
Thursday, 8 November 2018
The Leukaemia Foundation and the Haematology Society of Australia and New Zealand (HSANZ) are proud to announce the co-funding of three Australian Clinical and Science PhD investigators, whose work will focus on understanding blood cancer biology and the development of new diagnostics and precision medicines.
“It is
Position Statement: Glyphosate
Updated 17 June 2019
The Leukaemia Foundation’s CEO Bill Petch said the Leukaemia Foundation had been closely monitoring the issue of glyphosate for many years. It accepts the position of the APVMA as the Australian regulatory body, however, as the last review was undertaken in early 2017, we encourage the
Leukaemia Foundation supports WEHI’s new laboratory model to test anti-cancer drugs
Tuesday, 16 October 2018
A new model which mimics the complexity of human cancers to allow for more accurate testing of anti-cancer drugs has been developed by leading Australian researchers at the Walter and Eliza Hall Institute (WEHI) in Melbourne.
Led by PhD students Ms Margs Brennan and Dr Gemma Kelly
Leukaemia Foundation supports Health Minister’s call to introduce ground breaking CAR-T Cell therapies into Australian Public Hospitals
Tuesday, 16 October 2018
The Leukaemia Foundation has come out in support of today’s call by Federal Health Minister Greg Hunt to fast track the revolutionary CAR T-Cell therapy into Australian hospitals.
CAR-T cell therapy involves harvesting a patient’s T-cells, a type of immune cell, and genetically engineering them to attack
Congratulations to Nobel Prize immunotherapy pioneers
Thursday, 04 October 2018
The Leukaemia Foundation congratulates the 2018 Nobel Prize in Medicine winners, James Allison of the US and Tasuku Honjo of Japan, for their research and discovery into how the body’s natural defences can fight cancer such as lymphoma.
“As Australia’s leading blood cancer organisation, we acknowledge the